688062 迈威生物
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(103,031)(956,444)(782,728)(719,171)(422,403)
投资活动产生之现金流量净额(201,061)(291,554)(509,623)(602,803)12,836
筹资活动产生之现金流量净额517,247831,698444,9363,715,810198,942
汇率变动对现金及现金等价物的影响(1,292)2331,4032,264(1,006)
现金及现金等价物净增加/(减少)211,863(416,067)(846,011)2,396,100(211,630)
期初现金及现金等价物余额1,227,5661,643,6332,489,64593,545305,175
期末现金及现金等价物余额1,439,4291,227,5661,643,6332,489,64593,545